Weijuan Jia

Low-Dose Anti-Angiogenic Therapy Sensitizes Breast Cancer to PD-1 Blockade

Qian Li, Yifan Wang, Weijuan Jia et al. · Clinical Cancer Research · 2019 · 150 citations · Full text

Life Sciences, Immunology, Oncology +17

The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients

Weijuan Jia, Jiannan Wu, Haixia Jia et al. · PLoS ONE · 2015 · 108 citations · Full text

Medicine, Hematology, Oncology +14

Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer

Jieqiong Liu, Ying Wang, Zhenluan Tian et al. · Nature Communications · 2022 · 101 citations · Full text

Medicine, Oncology, Pharmacology +16

Plasma miR-221 as a Predictive Biomarker for Chemoresistance in Breast Cancer Patients who Previously Received Neoadjuvant Chemotherapy

Ruihua Zhao, Jiannan Wu, Weijuan Jia et al. · Onkologie · 2011 · 70 citations

Medicine, Molecular Medicine, Oncology +14

Psychological stress induces chemoresistance in breast cancer by upregulating mdr1

Fengxi Su, Nengyong Ouyang, Pengcheng Zhu et al. · Biochemical and Biophysical Research Communications · 2005 · 69 citations

Medicine, Cancer Biology, Oncology +11